Diagnosis and Management of Traumatic Subarachnoid Hemorrhage: Protocol for a Scoping Review.
SAH
TBI
diagnostic criteria
management
neurosurgery
neurotrauma
scoping review
trauma
Journal
JMIR research protocols
ISSN: 1929-0748
Titre abrégé: JMIR Res Protoc
Pays: Canada
ID NLM: 101599504
Informations de publication
Date de publication:
20 Oct 2021
20 Oct 2021
Historique:
received:
22
12
2020
accepted:
11
08
2021
revised:
11
08
2021
entrez:
20
10
2021
pubmed:
21
10
2021
medline:
21
10
2021
Statut:
epublish
Résumé
Globally, 69 million people suffer from traumatic brain injury (TBI) each year and TBI is the most common cause of subarachnoid hemorrhage (SAH). Traumatic SAH (TSAH) has been described as an adverse prognostic factor leading to progressive neurological deterioration and an increase in morbidity and mortality, but there are a limited number of studies which evaluate recent trends in the diagnostic and management of SAH in the context of trauma. The objective of this scoping review was to understand the extent and type of evidence in relation to the diagnostic criteria and management of TSAH. This scoping review will be conducted in accordance with the Joanna Briggs Institute methodology for scoping reviews. A 3-step search strategy (an initial limited search in PubMed and Scopus databases; a main search of EMBASE, Web of Science, EBSCO, MEDLINE; and manual searches of reference lists of included articles) will be utilized. The search will be limited to studies with human participants and published in English, Spanish, and French between 2005 and 2020. This review will consider studies of adolescent and adult patients with SAH secondary to trauma. Study selection will be performed by 2 authors (DG and LF) in a 2-phase process; if any disagreement arises, a third author (AR) will be consulted. Data to be extracted from each study will include population, intervention, comparator and outcome measures, and a summary of findings. Citation screening, full-text review, risk of bias assessment, and extraction of study characteristics and outcomes will be carried out using a web-based software platform that streamlines the production of scoping reviews. Ethics approval is not required for this systematic review, as there will be no patient involvement. The search for this systematic review commenced in December 2020, and we expect to publish the findings in early 2021. The plan for dissemination is to publish review findings in a peer-reviewed journal and present findings at conferences that engage the most pertinent stakeholders. This scoping review will serve as an initial step in providing more evidence for health care professionals, economists, and policymakers so that they might devote more resources toward this significant problem affecting both health and economic outcomes worldwide. PRR1-10.2196/26709.
Sections du résumé
BACKGROUND
BACKGROUND
Globally, 69 million people suffer from traumatic brain injury (TBI) each year and TBI is the most common cause of subarachnoid hemorrhage (SAH). Traumatic SAH (TSAH) has been described as an adverse prognostic factor leading to progressive neurological deterioration and an increase in morbidity and mortality, but there are a limited number of studies which evaluate recent trends in the diagnostic and management of SAH in the context of trauma.
OBJECTIVE
OBJECTIVE
The objective of this scoping review was to understand the extent and type of evidence in relation to the diagnostic criteria and management of TSAH.
METHODS
METHODS
This scoping review will be conducted in accordance with the Joanna Briggs Institute methodology for scoping reviews. A 3-step search strategy (an initial limited search in PubMed and Scopus databases; a main search of EMBASE, Web of Science, EBSCO, MEDLINE; and manual searches of reference lists of included articles) will be utilized. The search will be limited to studies with human participants and published in English, Spanish, and French between 2005 and 2020. This review will consider studies of adolescent and adult patients with SAH secondary to trauma. Study selection will be performed by 2 authors (DG and LF) in a 2-phase process; if any disagreement arises, a third author (AR) will be consulted. Data to be extracted from each study will include population, intervention, comparator and outcome measures, and a summary of findings. Citation screening, full-text review, risk of bias assessment, and extraction of study characteristics and outcomes will be carried out using a web-based software platform that streamlines the production of scoping reviews.
RESULTS
RESULTS
Ethics approval is not required for this systematic review, as there will be no patient involvement. The search for this systematic review commenced in December 2020, and we expect to publish the findings in early 2021. The plan for dissemination is to publish review findings in a peer-reviewed journal and present findings at conferences that engage the most pertinent stakeholders.
CONCLUSIONS
CONCLUSIONS
This scoping review will serve as an initial step in providing more evidence for health care professionals, economists, and policymakers so that they might devote more resources toward this significant problem affecting both health and economic outcomes worldwide.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID)
UNASSIGNED
PRR1-10.2196/26709.
Identifiants
pubmed: 34668871
pii: v10i10e26709
doi: 10.2196/26709
pmc: PMC8567149
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e26709Informations de copyright
©Dylan P Griswold, Laura Fernandez, A M Rubiano. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 20.10.2021.
Références
Trauma Surg Acute Care Open. 2019 Nov 17;4(1):e000313
pubmed: 31799413
Epilepsia. 2003;44(s10):2-10
pubmed: 14511388
Acta Neurochir Suppl. 2000;76:203-5
pubmed: 11450007
Neurol India. 2016 Mar-Apr;64 Suppl:S8-S13
pubmed: 26954974
J Neurosurg. 1994 Feb;80(2):291-300
pubmed: 8283269
Neurol Res. 2006 Jun;28(4):445-52
pubmed: 16759448
J Neurotrauma. 2014 Oct 15;31(20):1733-6
pubmed: 24926612
J Neurosurg. 2018 Apr 1;:1-18
pubmed: 29701556
Neurol Med Chir (Tokyo). 2017 Feb 15;57(2):82-93
pubmed: 28111406